Get my own profile
Public access
View all32 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Ton N.M. SchumacherThe Netherlands Cancer Institute, Third Rock VenturesVerified email at nki.nl
- Benoit P NicoletNetherlands Cancer Institute (NKI)Verified email at nki.nl
- EF. SmitHoogleraar longziektenVerified email at nki.nl
- Julian J. Freen-van HeerenSanquin Health Solutions, R&D, Immunomonitoring LaboratoryVerified email at sanquin.nl
- Marieke von lindernSanquin Research, and Landsteiner Lab. AMC/UvAVerified email at sanquin.nl
- Hans CleversHubrecht Institute - UtrechtVerified email at hubrecht.eu
- emile voestVerified email at nki.nl
- jan paul medemaHoogleraar Exp Oncology and RadiobiologyVerified email at amc.nl
- Stephen P. SchoenbergerLa Jolla Institute for ImmunologyVerified email at lji.org
- Maartje van den BiggelaarVerified email at sanquin.nl
- Derk AmsenVerified email at amc.nl
- Maarten SlagterNetherlands Cancer InstituteVerified email at nki.nl
- Joris van de HaarDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, AmsterdamVerified email at nki.nl
- Emile van den AkkerSanquinVerified email at sanquin.nl
- Martin TurnerThe Babraham Institute, Cambridge, CB22 3AT, UK.Verified email at babraham.ac.uk
- Julien J. KARRICHPostdoctoral fellowVerified email at sanquin.nl
- Jan NicoBouwes BavinckJan Nico Bouwes BavinckVerified email at lumc.nl
- Ramon ArensLeiden UniversityVerified email at lumc.nl
- S.C. JamesonUniversity of MinnesotaVerified email at umn.edu
- Sara E. HamiltonVerified email at umn.edu